Sleep Number Corp.

As of July 25, 2018, Sleep Number Corp. is considered risky due to its negative price-to-book value of -0.47, high EV to EBITDA ratio of 9.53, and significant underperformance with a one-year return of -54.77%, contrasting sharply with healthier valuations of peers like Ethan Allen and Arhaus.

As of July 25, 2018, Sleep Number Corp. is considered risky and overvalued with a negative P/E ratio and a price to book value of -0.47, significantly underperforming the S&P 500 with a year-to-date return of -54.40%.

As of June 2, 2025, the trend is mildly bearish due to daily moving averages, despite mixed signals from weekly indicators and the stock's underperformance compared to the S&P 500.

As of March 2022, the management team of Sleep Number Corp. includes Non-Executive Independent Chairman Jean-Michel Valette, President and CEO Shelly Ibach, and Independent Directors Daniel Alegre, Stephen Gulis, Michael Harrison, and Deborah Kilpatrick. They oversee the company's strategic direction and governance.

Sleep Number Corporation designs, manufactures, and sells Sleep Number beds, operating in the Furniture and Home Furnishing industry. As of March 2025, it reported net sales of $393 million and a net loss of $9 million, with a market capitalization of $164.06 million.

As of Jun 18, Sleep Number Corp. has a market capitalization of 164.06 million, classifying it as a Micro Cap company. As of Jun 24, net sales for the latest four quarters total 1,605.11 million, with a net profit of -21.51 million.